Customisable full service underpinned by the highest quality clinical conduct.
Charité Research Organisation focuses on supporting your early clinical development needs. Our aim is to help you transition your product from First Time in Human to Proof of Concept as efficiently and quickly as possible. The labels applied vary a little from company to company, but broadly speaking this means we are undertaking the first studies in humans, ‘typical’ Phase I type studies and ‘classical’ Phase IIa or even full Phase II studies. We are able to bring patients into the very first studies, in addition to healthy volunteers.